Literature DB >> 21619487

The Therapeutic Target Database: an internet resource for the primary targets of approved, clinical trial and experimental drugs.

Xin Liu, Feng Zhu, Xiaohua Ma, Lin Tao, Jingxian Zhang, Shengyong Yang, Yuquan Wei, Yu Zong Chen.   

Abstract

Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets. A challenge in drug discovery is to decide which targets to pursue from an increasing pool of potential targets, given the fact that few innovative targets have made it to the approval list each year. Knowledge of existing drug targets (both approved and within clinical trials) is highly useful for facilitating target discovery, selection, exploration and tool development. The Therapeutic Target Database (TTD) has been developed and updated to provide information on 358 successful targets, 251 clinical trial targets and 1254 research targets in addition to 1511 approved drugs, 1118 clinical trials drugs and 2331 experimental drugs linked to their primary targets (3257 drugs with available structure data). This review briefly describes the TTD database and illustrates how its data can be explored for facilitating target and drug searches, the study of the mechanism of multi-target drugs and the development of in silico target discovery tools.

Mesh:

Year:  2011        PMID: 21619487     DOI: 10.1517/14728222.2011.586635

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  10 in total

Review 1.  Bioinformatics opportunities for identification and study of medicinal plants.

Authors:  Vivekanand Sharma; Indra Neil Sarkar
Journal:  Brief Bioinform       Date:  2012-05-15       Impact factor: 11.622

2.  Study on the Mechanism of Treating Femoral Head Necrosis with Drynariae Rhizoma Based on Network Pharmacology.

Authors:  Luqing He; Chenyu Ma; Shuiqi Cai; Ruolin Hou; Hongfeng Xu; Jianqiang Liu; Xin Liu; Qun Huang
Journal:  Comput Math Methods Med       Date:  2022-06-06       Impact factor: 2.809

3.  Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction.

Authors:  Beihong Ji; Xibing He; Jingchen Zhai; Yuzhao Zhang; Viet Hoang Man; Junmei Wang
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

4.  HMPAS: Human Membrane Protein Analysis System.

Authors:  Min-Sung Kim; Gwan-Su Yi
Journal:  Proteome Sci       Date:  2013-11-07       Impact factor: 2.480

5.  Use of genome-wide association studies for cancer research and drug repositioning.

Authors:  Jizhun Zhang; Kewei Jiang; Liang Lv; Hui Wang; Zhanlong Shen; Zhidong Gao; Bo Wang; Yang Yang; Yingjiang Ye; Shan Wang
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

6.  Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis.

Authors:  Siliang Wang; Hengbin Wang; Yin Lu
Journal:  Oncotarget       Date:  2017-02-28

7.  Cancer diagnostics: The journey from histomorphology to molecular profiling.

Authors:  Atif A Ahmed; Malak Abedalthagafi
Journal:  Oncotarget       Date:  2016-09-06

8.  Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment.

Authors:  Ji Lv; Yitao Jia; Jing Li; Wentao Kuai; Yang Li; Fang Guo; Xinjian Xu; Zhaolong Zhao; Jian Lv; Zhongxin Li
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

Review 9.  Navigating the multilayered organization of eukaryotic signaling: a new trend in data integration.

Authors:  Tapesh Santra; Walter Kolch; Boris N Kholodenko
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

Review 10.  A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants.

Authors:  Xuanyi Li; Jeremy L Warner
Journal:  Front Cell Dev Biol       Date:  2020-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.